4th Quarter - Report

MEDECINS SANS FRONTIERES D/B/A DOCTORS WITHOUT BORDERS for MEDECINS SANS FRONTIERES D/B/A DOCTORS WITHOUT BORDERS

Period 4th Quarter 2024 Filed Jan 14, 2025 Signed by Nelli Ayvazyan

Official filing
Firm
MEDECINS SANS FRONTIERES D/B/A DOCTORS WITHOUT BORDERS
Client
MEDECINS SANS FRONTIERES D/B/A DOCTORS WITHOUT BORDERS
Income
—
Expenses
$85,758
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Increasing equitable access to medical tools Addressing Antibiotic Resistance Infectious Disease Outbreak and PPR Sexual and Reproductive Health

LobbyistCovered position, as disclosed
AVA ALKON —
MIHIR BHARAT MANKAD —
RACHEL MILKOVICH —
ALEX WADE New —

Contacted: Natl Institutes of Health (NIH); State, Dept of (DOS); Office of Science & Technology Policy (OSTP); Centers For Disease Control & Prevention (CDC); U.S. Agency for International Development (USAID); SENATE; Natl Security Council (NSC); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.